U.S. panel to review restrictions on Roche's Accutane

02/26/2004 | Reuters

The FDA will ask an outside panel of experts if tougher restrictions are needed on the use of Accutane, a highly effective prescription drug against acne but one that also can cause birth defects. The panel will review new data showing efforts to keep pregnant women from taking the drug with strongly worded warnings and controls have fallen short. A Roche spokeswoman said the drug maker has proposed new restrictions and will consider the advice of the panel.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA